Zobrazeno 1 - 10
of 3 139
pro vyhledávání: ''
Publikováno v:
OncoTargets and therapy
JunJie Yu,1,2 Si Sun,1,2 WeiPu Mao,1,2 Bin Xu,3 Ming Chen3– 5 1Surgical Research Center, Institute of Urology, School of Medicine, Southeast University, Nanjing, People’s Republic of China; 2Department of Medical College, Southeast University, Na
Publikováno v:
OncoTargets and therapy
Background Primary pancreatic mucoepidermoid carcinoma (MEC) is an extremely rare malignant tumor with unclear etiology and pathogenesis. There are only eleven reported cases in English papers published from 1959 to 2020. MEC generally occurs in the
Publikováno v:
OncoTargets and therapy
Epidermal growth factor receptor (EGFR) fusions are rare genomic events in non-small-cell lung cancer (NSCLC). With advances in detection technology, some uncommon genomic mutation events, including EGFR fusions, have been detected. There are no stan
Autor:
Hisham A. Abbas, Mahmoud Youns, Momen Askoura, Wael A H Hegazy, Ahmad J. Almalki, Ahdab N. Khayyat, Gouda H. Attia, Reham M. Goda, El-Sayed Khafagy
Publikováno v:
OncoTargets and Therapy. 14:3849-3860
Mahmoud Youns, 1, 2 Momen Askoura, 3 Hisham A Abbas, 3 Gouda H Attia, 4, 5 Ahdab N Khayyat, 6 Reham M Goda, 7 Ahmad J Almalki, 6 El-Sayed Khafagy, 8, 9 Wael AH Hegazy 3 1Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, Helwan Un
Publikováno v:
OncoTargets and therapy
Early T‐cell precursor acute lymphoblastic leukemia (ETP-ALL) is an aggressive and extremely fatal subtype of T-cell acute lymphoblastic leukemia (T-ALL), characterized by the similar transcriptional and immunophenotypic profiles to those of early
Autor:
Matthew J. Rendo, Guy T. Clifton, Anne E O'Shea, Alexandra M Adams, Timothy J. Vreeland, Joshua L. Fenderson, Patrick M. McCarthy, Daniel W. Nelson, Katherine M Cebe, Robert W Krell, George E. Peoples, Matthew D Uy
Publikováno v:
OncoTargets and therapy
Pancreatic ductal adenocarcinoma (PDAC) remains deadly despite advances in systemic therapies and surgical techniques. While there is increasing utilization of immune therapies across diverse cancer types, PDAC remains generally resistant to these tr
Publikováno v:
OncoTargets and therapy
Changbao Chen,1 Hua Zhou,2 Zhongjun Liu,2 Xinlong Ma1 1Department of Spinal Surgery, Tianjin Hospital, Tianjin, 300211, People’s Republic of China; 2Department of Orthopaedic Surgery, Peking University Third Hospital, Beijing, 100191, People’s Re
Autor:
Li Jing, Jun-Hui Sun, Feng Chen, Guo-Fang Tao, Tong-Yin Zhu, Tan-Yang Zhou, Chun-Hui Nie, Zi-Niu Yu, Guan-Hui Zhou, Bao-Quan Wang, Sheng-Qun Chen, Yue-Lin Zhang, Hong-Liang Wang
Publikováno v:
OncoTargets and therapy
Background Hepatocellular carcinoma (HCC) associated with macroscopic vascular invasion and distant metastasis is an advanced-stage disease with an extremely poor prognosis and low survival rate. Therefore, there is an urgent need to develop novel th
Publikováno v:
OncoTargets and therapy
Fangyuan Cao,1,2 Mumu Shi,1 Bo Yu,1 Xiangrong Cheng,3 Xin Li,4 Xinshan Jia5 1Department of Pathology, Science and Education Department of the Fifth People’s Hospital of Qinghai, Xining, Qinhai, 810000, People’s Republic of China; 2Department of P
Publikováno v:
OncoTargets and therapy
Qian Chen,1,2,* Hongyu Zhang,3,4,* Jianyin Zhang,1,2 Le Shen,1,2 Jing Yang,1,2 Yan Wang,1,2 JinXiu Ma,1,2 Bing Zhuan1,2 1Department of Respiratory Medicine, People’s Hospital of Ningxia Hui Autonomous Region, Yinchuan, People’s Republic of China;